Take guesswork out of due diligence around the strength of IP in that new portfolio opportunity
Do you want to reduce risk and increase value in your life science investments? Do you want to take the guesswork out of your due diligence process around the strength of IP in that new portfolio opportunity? If you do, then you can benefit from Cresset’s computational chemistry consulting expertise, which has been built up over more than 25 years. Our core software is used every day by global pharma companies to validate their R&D concepts, and our consulting offering has been used in nearly 300+ discovery projects over the last 20 years, with an excellent success rate. If your portfolio companies are not ready yet to invest in in-house computational chemistry, then we can give your businesses cost effective access to this critical drug discovery technology through Cresset Discovery. We offer expertize in virtual screening, library design, SAR analysis, IP/Patent analysis and more to help your investees answer questions such as:
When your management teams are in a position to recruit their own in-house resources, we will be there to support them with the best software, training and support. Outsourcing a drug discovery project to Cresset means:
Our goal is to help you achieve maximum return on your investments with minimum risk of expensive failures.
We help you reach your next milestone faster and more cost effectively